Year: 2019
Type: article
Abstract: As patients with genetic diseases seek to have healthy biologically connected children, they will undoubtedly turn to trusted health care professionals for guidance."Doctor, should I enter a clinical trial to edit my embryos?" is likely to become a query posed by patients with genetic illnesses.Physicians need both empathic communication skills and a framework for responding to this question.Applying the 4-S framework to gene editing can guide clinicians' responses to patients' CRISPR queries by facilitating discussion of (1) safety, (2) significance of harm to be averted, (3) impact on succeeding generations, and (4) social consequences.The views expressed are those of the author(s) and do not represent the views of the federal government or the US Department of Veterans Affairs.The people and events in this case are fictional.Resemblance to real events or to names of people, living or dead, is entirely coincidental.The viewpoints expressed in this article are those of the author(s) and do not necessarily reflect the views and policies of the AMA.
Source: The AMA Journal of Ethic
Author: Lisa S. Lehmann
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2991486743